Implantable Contact Lenses Provide New Hope to Nearsighted Patients
Many residents of southern Utah residents - previously not qualified for LASIK - can now achieve excellent vision with the new Implantable Collamer Lens (ICL). The new lens is actually implanted into a patient’s eye through a tiny, 3 mm incision that requires no stitches and is minimally invasive. The technology was recently approved by the U.S Food and Drug Administration.
The Zion Eye institute’s Dr. Cohen, who is among one of the first trained eye surgeons in the nation for the new ICL procedure says. “This phakic IOL is truly a major step forward in eye technology. It is such powerful medicine that all my patients who have had LASIK in one eye and the ICL in the other seem to prefer their vision in the ICL eye.”
The best candidates for ICL are people between the ages of 25 and 45 with moderate to severe myopia or nearsightedness. According to the developer of the ICL, the new lens is made of Collamer, a highly biocompatible material containing pure collagen, making it very stable and well-suited for the eye causing no adverse reactions. The lens also filters out ultraviolet rays, an extra benefit especially in the sunny southern Utah.
“The lens does not attach into any structures within the eye and yet it stays in place after the procedure,” continues Dr. Cohen. “I’m truly excited about this new technology. It’s a blessing to those people who have not been candidates for Lasik vision correction in the past.”
The new ICL procedure is currently available only at Zion Eye Institute. Other clinics will be able to offer it sometime in the future.
Or